These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21228155)

  • 21. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration.
    Zhang W; Cheng W; Parlato R; Guo X; Cui X; Dai C; Xu L; Zhu J; Zhu M; Luo K; Zhang W; Dong B; Wang J; Jiang F
    Aging (Albany NY); 2020 Nov; 12(21):22174-22198. PubMed ID: 33146634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.
    Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P
    Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
    J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism.
    Mandir AS; Simbulan-Rosenthal CM; Poitras MF; Lumpkin JR; Dawson VL; Smulson ME; Dawson TM
    J Neurochem; 2002 Oct; 83(1):186-92. PubMed ID: 12358742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
    Goudarzi KM; Nistér M; Lindström MS
    Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR Signaling in Parkinson's Disease.
    Lan AP; Chen J; Zhao Y; Chai Z; Hu Y
    Neuromolecular Med; 2017 Mar; 19(1):1-10. PubMed ID: 27263112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease in mice.
    Liu H; Wu H; Zhu N; Xu Z; Wang Y; Qu Y; Wang J
    J Neurochem; 2020 Feb; 152(3):397-415. PubMed ID: 31442326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
    Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
    J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
    Bao XQ; Kong XC; Qian C; Zhang D
    Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yamaguchi H; Kajitani K; Dan Y; Furuichi M; Ohno M; Sakumi K; Kang D; Nakabeppu Y
    Cell Death Differ; 2006 Apr; 13(4):551-63. PubMed ID: 16273081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson's disease models.
    Zhuang XX; Wang SF; Tan Y; Song JX; Zhu Z; Wang ZY; Wu MY; Cai CZ; Huang ZJ; Tan JQ; Su HX; Li M; Lu JH
    Cell Death Dis; 2020 Feb; 11(2):128. PubMed ID: 32071296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
    J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.